• DE
  • |
  • EN
  • Menü

Translational Neurodegeneration Section "Albrecht Kossel"

Universitätsmedizin Rostock
  • Zur Startseite
  • Albrecht Kossel
  • About
    • Lab Members
    • How to find us
    • Equipment
      • Autoclave
      • Safety workbench
      • LSM900
  • Information for patients
    • Diseases
      • ALS, SMA and other motor neurone diseases
      • Neuroacanthocytosis syndromes and neurodegeneration with iron accumulation in the brain
    • Consultation times and appointments
    • Advance directive
  • Current information
    • News from basic research
      • Lyn kinase activity as a therapeutic target for chorea acanthocytosis
      • FUS aggregates in ALS due to defective DNA repair
    • New therapies and findings from the clinic
      • TOFERSEN (Qalsody®) approved for patients with SOD1-ALS in Europe
      • RELYVRIO at ALS
  • Research Groups
    • Medical Genetics
    • Molecular Neurobiology
    • Translational Neurodegeneration
    • Cellular Neurophysiology
    • Research Group Cognition ALS
  • Publications
  • Donation account
  • Open Positions
header
  1. Current information
  2. News from basic research

News from basic research

  • Lyn kinase activity as a therapeutic target for chorea acanthocytosis
  • FUS aggregates in ALS due to defective DNA repair
  • Universität Rostock

Besuchen Sie uns
Facebook Instagram YouTube LinkedIn Xing
  • Intranet
  • Login (für Studenten)
  • Impressum
  • Datenschutzhinweise
  • Barrierefreiheit